🚀 VC round data is live in beta, check it out!

Botanee Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for Botanee Group and similar public comparables like Blue Moon Group, Chicmax Cosmetic, Softcare, Anhui Anke Biotechnology and more.

Botanee Group Overview

About Botanee Group

Yunnan Botanee Bio-Technology Group Co Ltd manufactures and sells skin care and cosmetics. The company develops and sells skin care products such as creams, lotions, masks, essences, and makeup items like BB creams, isolation creams, and removers. It also produces skin care-related medical devices, including hyaluronic acid repair films and dressings, used for protecting sensitive skin and post-procedure care.


Founded

2010

HQ

China

Employees

4.0K

Financials (LTM)

Revenue: $831M
EBITDA: $101M

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Botanee Group Financials

Botanee Group reported last 12-month revenue of $831M and EBITDA of $101M.

In the same LTM period, Botanee Group generated $616M in gross profit, $101M in EBITDA, and $82M in net income.

Revenue (LTM)


Botanee Group P&L

In the most recent fiscal year, Botanee Group reported revenue of $841M and EBITDA of $120M.

Botanee Group expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Botanee Group forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$831MXXX$841MXXXXXXXXX
Gross Profit$616MXXX$620MXXXXXXXXX
Gross Margin74%XXX74%XXXXXXXXX
EBITDA$101MXXX$120MXXXXXXXXX
EBITDA Margin12%XXX14%XXXXXXXXX
EBIT Margin11%XXX10%XXXXXXXXX
Net Profit$82MXXX$74MXXXXXXXXX
Net Margin10%XXX9%XXXXXXXXX

Financial data powered by Morningstar, Inc.

Botanee Group Stock Performance

Botanee Group has current market cap of $2B, and enterprise value of $2B.

Market Cap Evolution


Botanee Group's stock price is $5.39.

See Botanee Group trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$2B0.0%XXXXXXXXX$0.17

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Botanee Group Valuation Multiples

Botanee Group trades at 2.2x EV/Revenue multiple, and 18.1x EV/EBITDA.

See valuation multiples for Botanee Group and 15K+ public comps

EV / Revenue (LTM)


Botanee Group Financial Valuation Multiples

As of April 20, 2026, Botanee Group has market cap of $2B and EV of $2B.

Equity research analysts estimate Botanee Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Botanee Group has a P/E ratio of 27.7x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$2BXXX$2BXXXXXXXXX
EV (current)$2BXXX$2BXXXXXXXXX
EV/Revenue2.2xXXX2.2xXXXXXXXXX
EV/EBITDA18.1xXXX15.3xXXXXXXXXX
EV/EBIT20.8xXXX21.5xXXXXXXXXX
EV/Gross Profit3.0xXXX2.9xXXXXXXXXX
P/E27.7xXXX31.0xXXXXXXXXX
EV/FCF18.1xXXX31.5xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Botanee Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Botanee Group Margins & Growth Rates

Botanee Group's revenue in the last 12 month grew by 8%.

Botanee Group's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Botanee Group's rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Botanee Group's rule of X is 35% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Botanee Group and other 15K+ public comps

Botanee Group Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth8%XXX(4%)XXXXXXXXX
EBITDA Margin12%XXX14%XXXXXXXXX
EBITDA Growth22%XXX(22%)XXXXXXXXX
Rule of 40—XXX22%XXXXXXXXX
Bessemer Rule of X—XXX35%XXXXXXXXX
Revenue per Employee—XXX$0.2MXXXXXXXXX
Opex per Employee—XXX$0.1MXXXXXXXXX
S&M Expenses to Revenue50%XXX47%XXXXXXXXX
G&A Expenses to Revenue8%XXX9%XXXXXXXXX
R&D Expenses to Revenue5%XXX5%XXXXXXXXX
Opex to Revenue—XXX64%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Botanee Group Public Comps

See public comps and valuation multiples for other Health & Beauty comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
Botanee GroupXXXXXXXXXXXXXXXXXX
Blue Moon GroupXXXXXXXXXXXXXXXXXX
Chicmax CosmeticXXXXXXXXXXXXXXXXXX
SoftcareXXXXXXXXXXXXXXXXXX
Anhui Anke BiotechnologyXXXXXXXXXXXXXXXXXX
EmamiXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Botanee Group M&A Activity

Botanee Group acquired XXX companies to date.

Last acquisition by Botanee Group was on XXXXXXXX, XXXXX. Botanee Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Botanee Group

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Botanee Group Investment Activity

Botanee Group invested in XXX companies to date.

Botanee Group made its latest investment on XXXXXXXX, XXXXX. Botanee Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Botanee Group

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Botanee Group

When was Botanee Group founded?Botanee Group was founded in 2010.
Where is Botanee Group headquartered?Botanee Group is headquartered in China.
How many employees does Botanee Group have?As of today, Botanee Group has over 4K employees.
Is Botanee Group publicly listed?Yes, Botanee Group is a public company listed on Shenzhen Stock Exchange.
What is the stock symbol of Botanee Group?Botanee Group trades under 300957 ticker.
When did Botanee Group go public?Botanee Group went public in 2021.
Who are competitors of Botanee Group?Botanee Group main competitors are Blue Moon Group, Chicmax Cosmetic, Softcare, Anhui Anke Biotechnology.
What is the current market cap of Botanee Group?Botanee Group's current market cap is $2B.
What is the current revenue of Botanee Group?Botanee Group's last 12 months revenue is $831M.
What is the current revenue growth of Botanee Group?Botanee Group revenue growth (NTM/LTM) is 8%.
What is the current EV/Revenue multiple of Botanee Group?Current revenue multiple of Botanee Group is 2.2x.
Is Botanee Group profitable?Yes, Botanee Group is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Botanee Group?Botanee Group's last 12 months EBITDA is $101M.
What is Botanee Group's EBITDA margin?Botanee Group's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of Botanee Group?Current EBITDA multiple of Botanee Group is 18.1x.
What is the current FCF of Botanee Group?Botanee Group's last 12 months FCF is $101M.
What is Botanee Group's FCF margin?Botanee Group's last 12 months FCF margin is 12%.
What is the current EV/FCF multiple of Botanee Group?Current FCF multiple of Botanee Group is 18.1x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial